Clinical Trial

Clinical Trial Search

Click here to learn more about participating in Clinical Trials.

Trial Protocol ID USOR 23083_D798AC00001_eVOLVE-Lung02

Trial Description

A Phase III, Two-Arm, Parallel, Randomized, Multi-Center,Open-Label, Global Study to Determine the Efficacy of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer (mNSCLC) (eVOLVE-Lung02) (D798AC00001)

View on ClinicalTrials.gov

Investigator

Vinni Juneja, MD

Disease Types

Lung Cancer

ClinicalTrials.gov NCT ID

NCT05984277